Literature DB >> 16418239

Multi-detector row CT of hemoptysis.

John F Bruzzi1, Martine Rémy-Jardin, Damien Delhaye, Antoine Teisseire, Chadi Khalil, Jacques Rémy.   

Abstract

Hemoptysis is symptomatic of a potentially life-threatening condition and warrants urgent and comprehensive evaluation of the lung parenchyma, airways, and thoracic vasculature. Multi-detector row computed tomographic (CT) angiography is a very useful noninvasive imaging modality for initial assessment of hemoptysis. The combined use of thin-section axial scans and more complex reformatted images allows clear depiction of the origins and trajectories of abnormally dilated systemic arteries that may be the source of hemorrhage and that may require embolization. Conditions such as bronchiectasis, chronic bronchitis, lung malignancy, tuberculosis, and chronic fungal infection are some of the most common underlying causes of hemoptysis and are easily detected with CT. "Cryptogenic" hemoptysis is common among smokers and warrants subsequent follow-up imaging to exclude possible underlying malignancy. The bronchial arteries are the source of bleeding in most cases of hemoptysis. Contributions from the non-bronchial systemic arterial system represent an important cause of recurrent hemoptysis following apparently successful bronchial artery embolization. Vascular anomalies such as pulmonary arteriovenous malformations and bronchial artery aneurysms are other important causes of hemoptysis. Multi-detector row CT angiography permits noninvasive, rapid, and accurate assessment of the cause and consequences of hemorrhage into the airways and helps guide subsequent management. (c) RSNA, 2006.

Entities:  

Mesh:

Year:  2006        PMID: 16418239     DOI: 10.1148/rg.261045726

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  39 in total

1.  An unusual cause of hemoptysis: costocervical trunk pseudoaneurysm.

Authors:  Manphool Singhal; Suresh Giragani; Anupam Lal; Aman Sharma; Niranjan Khandelwal
Journal:  Emerg Radiol       Date:  2010-10-07

Review 2.  Imaging in noncardiovascular thoracic emergencies: a pictorial review.

Authors:  Ashish Chawla
Journal:  Singapore Med J       Date:  2015-11       Impact factor: 1.858

3.  Haemoptysis from the pulmonary artery.

Authors:  Shih-Hung Tsai; Wei-Chou Chang; Shi-Jye Chu; Hsien-He Hsu
Journal:  Emerg Med J       Date:  2007-08       Impact factor: 2.740

Review 4.  A friend to the airways: a review of the emerging clinical importance of the bronchial arterial circulation.

Authors:  Stephen Osiro; Christopher Wear; Ryan Hudson; Xiao-Xiao Ma; Anna Zurada; Maciej Michalak; Marios Loukas
Journal:  Surg Radiol Anat       Date:  2012-05-03       Impact factor: 1.246

5.  Radiological findings and outcomes of bronchial artery embolization in cryptogenic hemoptysis.

Authors:  Selim Kervancioglu; Nazan Bayram; Feyza Gelebek Yilmaz; Maruf Sanli; Akif Sirikci
Journal:  J Korean Med Sci       Date:  2015-04-15       Impact factor: 2.153

6.  Anomalies of Pulmonary Circulation as a Cause of Hemoptysis: A Series of Unusual Cases and Review of the Literature.

Authors:  Kamini Gupta; Kavita Saggar; Amit Goyal; Avik Banerjee
Journal:  Oman Med J       Date:  2015-05

7.  [Bronchial and nonbronchial systemic artery embolization in managing haemoptysis: 31 years of experience].

Authors:  G P Cornalba; A Vella; F Barbosa; G Greco; C Michelozzi; A Sacrini; F Melchiorre
Journal:  Radiol Med       Date:  2012-08-09       Impact factor: 3.469

8.  Haemoptysis from the pulmonary artery.

Authors:  S-H Tsai; S-J Chu; W-C Chang; H-H Hsu
Journal:  BMJ Case Rep       Date:  2009-01-08

9.  Bronchial artery embolization for hemoptysis.

Authors:  Manrita Sidhu; Karen Wieseler; Thomas R Burdick; Dennis W W Shaw
Journal:  Semin Intervent Radiol       Date:  2008-09       Impact factor: 1.513

10.  Controlling hemoptysis: An alternative approach.

Authors:  Rakesh K Chawla; Arun Madan; Dinesh Mehta; Kiran Chawla
Journal:  Lung India       Date:  2010-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.